Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Morgan Stanley Reiterates Equal-Weight on Nautilus Biotechnology, Maintains $6 Price Target

Author: Benzinga Newsdesk | August 03, 2023 11:22am

Morgan Stanley analyst Tejas Savant reiterates Nautilus Biotechnology (NASDAQ:NAUT) with a Equal-Weight and maintains $6 price target.

Posted In: NAUT